Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention

被引:17
|
作者
Zhou, You [1 ]
Chen, Zhangwei [1 ]
Ma, Jiaqi [1 ]
Chen, Ao [1 ]
Lu, Danbo [1 ]
Wu, Yuan [1 ]
Ren, Daoyuan [1 ]
Zhang, Chi [1 ]
Dai, Chunfeng [1 ]
Zhang, Yaqi [1 ]
Qian, Juying [1 ]
Ge, Junbo [1 ]
机构
[1] Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Dept Cardiol, 180 Fenglin Rd, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
Periprocedural myocardial injury; Percutaneous coronary intervention; Cardiac troponin T; CREATINE KINASE-MB; CARDIAC TROPONIN-T; PROGNOSTIC VALUE; MICROEMBOLIZATION; INFARCTION; MYONECROSIS; ELEVATION; DIAGNOSIS; IMPACT; DAMAGE;
D O I
10.1016/j.jjcc.2020.03.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although technological and equipment innovations have given rise to delicate and safe coronary intervention procedures, periprocedural myocardial injury (PMI) is still one of the common complications. The relationship between PMI, defined by various biomarker thresholds, and clinical prognosis remains controversial. We sought to assess the determinants and prognosis of PMI in patients with stable coronary artery disease (CAD) undergoing elective percutaneous coronary intervention (PCI). Methods: Consecutive stable CAD patients with negative preoperative troponin T levels undergoing elective PCI in our hospital were enrolled from July 2017 to December 2017. PMI was defined as troponin T values >99th percentile upper reference limit (URL) within 16-24 h post-PCI. The correlation of cardiovascular events and PMI was assessed after a median follow-up of 18 months. Results: PMI occurred in 45.3% of the 1572 patients included, with 11.2% having troponin T levels elevated more than 5 times the URL after PCI. Independent risk factors for PMI were age >= 65 years, prior PCI, bifurcation lesion, stent number, and multivessel disease. During the follow-up period, patients with PMI had a higher incidence of unplanned revascularization [10.8% vs. 7.2%, adjusted hazard ratio (adHR) 1.40, 95% confidence interval (CI) 1.04-2.06; p = 0.045] and target vessel revascularization (5.8% vs. 2.7%, adHR 1.90, 95% CI 1.06-3.38; p = 0.030) than those without PMI. However, no significant impact of PMI on the risk of death and myocardial infarction was found. Conclusions: PMI defined by troponin T levels >99th percentile URL correlated with an increased risk of cardiovascular events in stable CAD patients undergoing elective PCI. (C) 2020 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:309 / 316
页数:8
相关论文
共 50 条
  • [31] Predictive Value of Aortic Valve Calcification for Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention
    Shibata, Yohei
    Ishii, Hideki
    Suzuki, Susumu
    Tanaka, Akihito
    Tatami, Yosuke
    Harata, Shingo
    Ota, Tomoyuki
    Shimbo, Yusaku
    Takayama, Yohei
    Kunimura, Ayako
    Hirayama, Kenshi
    Harada, Kazuhiro
    Osugi, Naohiro
    Murohara, Toyoaki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2017, 24 (05) : 487 - 494
  • [32] Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions
    Koskinas, Konstantinos C.
    Ndrepepa, Gjin
    Raeber, Lorenz
    Karagiannis, Alexios
    Kufner, Sebastian
    Zanchin, Thomas
    Hieber, Julia
    Hunziker, Lukas
    Mayer, Katharina
    Byrne, Robert A.
    Heg, Dik
    Windecker, Stephan
    Kastrati, Adnan
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (12)
  • [33] Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury
    Mulukutla, SR
    Marroquin, OC
    Smith, C
    Varghese, R
    Anderson, WD
    Lee, JS
    Cohen, HA
    Counihan, PJ
    Lee, AB
    Gulati, V
    McNamara, D
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (11): : 1363 - 1366
  • [34] Can prasugrel decrease the extent of periprocedural myocardial injury during elective percutaneous coronary intervention?
    Tomaniak, Mariusz
    Koltowski, Lukasz
    Kochman, Janusz
    Huczek, Zenon
    Rdzanek, Adam
    Pietrasik, Arkadiusz
    Gasecka, Aleksandra
    Gajda, Sylwia
    Opolski, Grzegorz
    Filipiak, Krzysztof J.
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (11): : 730 - 740
  • [35] Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented?
    Cuculi, F.
    Lim, C. C. S.
    Banning, A. P.
    HEART, 2010, 96 (10) : 736 - 740
  • [36] Effect of remote ischemic preconditioning in periprocedural myocardial injury events in elective percutaneous coronary intervention
    Anggriyani, N.
    Rifqi, S.
    Uddin, I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 5 - 5
  • [37] Impact of increased inflammation biomarkers on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention: a cohort study
    Zhao, Liding
    Li, Ya
    Xu, Tian
    Luan, Yi
    Lv, Qingbo
    Wang, Yao
    Lv, Xue
    Fu, Guosheng
    Zhang, Wenbin
    JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 5398 - +
  • [38] Association of Pre-procedural Nutritional Indicators with Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Intervention
    Liu, Lu
    Jin, Jinhua
    Wang, Manjun
    Xu, Xiaoyun
    Jiang, Hangpan
    Chen, Zhezhe
    Li, Ya
    Gao, Jing
    Zhang, Wenbin
    INTERNATIONAL HEART JOURNAL, 2023, 64 (03) : 417 - 426
  • [39] Predictors of periprocedural creatine kinase-myocardial band elevation complicating elective percutaneous coronary intervention
    Cai, Qiangjun
    Skelding, Kimberly A.
    Armstrong, Arthur T., Jr.
    Desai, Dipan
    Wood, G. Craig
    Blankenship, James C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (05): : 616 - 620
  • [40] Impact of Tongguan Capsule on periprocedural myocardial injury undergoing percutaneous coronary intervention in coronary heart disease
    Zeng, Ruixiang
    Chen, Zhiqiang
    Zhang, Minzhou
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C164 - C164